130 related articles for article (PubMed ID: 2439252)
1. Food-induced gastric retention and absorption of sustained-release procainamide.
Rocci ML; Mojaverian P; Davis RJ; Ferguson RK; Vlasses PH
Clin Pharmacol Ther; 1987 Jul; 42(1):45-9. PubMed ID: 2439252
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of procainamide and N-acetylprocainamide in rats.
Kamath BL; Lai CM; Gupta SD; Durrani MJ; Yacobi A
J Pharm Sci; 1981 Mar; 70(3):299-302. PubMed ID: 6167709
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
[TBL] [Abstract][Full Text] [Related]
4. Thin-layer chromatographic determination of procainamide and N-acetylprocainamide in human serum and urine at single-dose levels.
Kark B; Sistovaris N; Keller A
J Chromatogr; 1983 Oct; 277():261-72. PubMed ID: 6196373
[TBL] [Abstract][Full Text] [Related]
5. Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography.
Lai CM; Kamath BL; Look ZM; Yacobi A
J Pharm Sci; 1980 Aug; 69(8):982-4. PubMed ID: 6157019
[TBL] [Abstract][Full Text] [Related]
6. Absorption kinetics of procainamide in humans.
Manion CV; Lalka D; Baer DT; Meyer MB
J Pharm Sci; 1977 Jul; 66(7):981-4. PubMed ID: 886461
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of N-acetylprocainamide.
Connolly SJ; Kates RE
Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545
[TBL] [Abstract][Full Text] [Related]
8. Serum drug concentrations in patients with ischemic heart disease after administration of a sustained release procainamide preparation.
Zema MJ; Mirando T
Angiology; 1983 Jan; 34(1):32-9. PubMed ID: 6186164
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
[TBL] [Abstract][Full Text] [Related]
10. Procainamide absorption studies to test the feasibility of using a sustained-release preparation.
Shaw TR; Kumana CR; Kaye CM; Padgham C; Kaspi T; Hamer J
Br J Clin Pharmacol; 1975 Dec; 2(6):515-9. PubMed ID: 1234015
[TBL] [Abstract][Full Text] [Related]
11. Immediate-release and sustained-release procainamide: bioavailability at steady state in cardiac patients.
Vlasses PH; Rocci ML; Porrini KA; Greenspon AJ; Ferguson RK
Ann Intern Med; 1983 May; 98(5 Pt 1):613-4. PubMed ID: 6189438
[No Abstract] [Full Text] [Related]
12. More-sensitive enzyme-multiplied immunoassay technique for procainamide and N-acetylprocainamide in plasma, serum, and urine.
Henry PR; Dhruv RA
Clin Chem; 1988 May; 34(5):957-60. PubMed ID: 2453309
[TBL] [Abstract][Full Text] [Related]
13. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.
Mojaverian P; Rocci ML; Conner DP; Abrams WB; Vlasses PH
Clin Pharmacol Ther; 1987 Jan; 41(1):11-7. PubMed ID: 3802700
[TBL] [Abstract][Full Text] [Related]
14. Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide.
Ylitalo P; Ruosteenoja R; Leskinen O; Metsä-Ketelä T
Eur J Clin Pharmacol; 1983; 25(6):791-5. PubMed ID: 6198178
[TBL] [Abstract][Full Text] [Related]
15. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat.
Bruguerolle B; Jadot G
J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation.
Giardina EG; Fenster PE; Bigger JT; Mayersohn M; Perrier D; Marcus FI
Am J Cardiol; 1980 Nov; 46(5):855-62. PubMed ID: 6159783
[TBL] [Abstract][Full Text] [Related]
17. [Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation].
Pirovino M; Karlaganis G; Galeazzi RL
Schweiz Med Wochenschr; 1980 Sep; 110(39):1415-9. PubMed ID: 6169144
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of N-acetylprocainamide from mixed diet in rats.
Kamath BL; Yacobi A; Gupta SD; Stampfli H; Durrani M; Lai CM
Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):299-308. PubMed ID: 6166034
[TBL] [Abstract][Full Text] [Related]
19. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
Jung D; Nanavaty M; Prasad P
Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
[TBL] [Abstract][Full Text] [Related]
20. Comparative bioequivalence and efficacy of two sustained-release procainamide formulations in patients with cardiac arrhythmias.
Hilleman DE; Patterson AJ; Mohiuddin SM; Ortmeier BG; Destache CJ
Drug Intell Clin Pharm; 1988; 22(7-8):554-8. PubMed ID: 2458219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
